TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards July 31, 2009
TCL Archive Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists April 12, 2013
TCL Archive In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned July 11, 1980
